Performance of PHVS Pharvaris BV | 36.8% in 12m
Compare PHVS with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Pharvaris BV with its related Sector/Index XBI
Performance Duell PHVS vs XBI
| TimeFrame | PHVS | XBI |
|---|---|---|
| 1 Week | -2.27% | 2.09% |
| 1 Month | 27.7% | 4.45% |
| 3 Months | 34.8% | 7.71% |
| 6 Months | 2.34% | 11.24% |
| 12 Months | 36.8% | 44.21% |
| YTD | -10.3% | 11.67% |
| Rel. Perf. 1m | 2.43 | |
| Rel. Perf. 3m | 2.83 | |
| Rel. Perf. 6m | -0.28 | |
| Rel. Perf. 12m | -0.52 | |
| Spearman 1m | 0.92 | 0.236 |
| Spearman 3m | 0.71 | -0.066 |
Is Pharvaris BV a good stock to buy?
No, based on ValueRay Fundamental Analyses, Pharvaris BV (NASDAQ:PHVS) is currently (November 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -76.00 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHVS as of November 2024 is 20.83. This means that PHVS is currently overvalued and has a potential downside of -10.25% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PHVS as of November 2024 is 20.83. This means that PHVS is currently overvalued and has a potential downside of -10.25% (Sold with Premium).
Is PHVS a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 0
- Sell: 1
- Strong Sell: 0
Values above 0%: PHVS is performing better - Values below 0%: PHVS is underperforming
Compare PHVS with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.40% | 26.17% | -10.00% | 2.62% |
| US NASDAQ 100 | QQQ | -0.68% | 25.64% | -9.80% | 2.54% |
| US Dow Jones Industrial 30 | DIA | -5.94% | 23.50% | -11.16% | 6.28% |
| German DAX 40 | DAX | -0.57% | 29.33% | -1.70% | 11.22% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.49% | 48.54% | -8.92% | 23.43% |
| Hongkong Hang Seng | HSI | -3.99% | 37.42% | -8.11% | 27.37% |
| India NIFTY 50 | INDA | -1.38% | 30.09% | -2.20% | 12.87% |
| Brasil Bovespa | EWZ | -1.84% | 31.61% | 12.59% | 42.93% |
PHVS Pharvaris BV vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.16% | 23.89% | -12.84% | -2.92% |
| Consumer Discretionary | XLY | -3.62% | 23.72% | -10.99% | 9.23% |
| Consumer Staples | XLP | -2.85% | 27.47% | -5.57% | 16.01% |
| Energy | XLE | -4.92% | 31.31% | 4.11% | 27.93% |
| Financial | XLF | -1.82% | 24.15% | -12.26% | -4.19% |
| Health Care | XLV | -1.90% | 29.81% | -3.02% | 19.67% |
| Industrial | XLI | -2.62% | 27.06% | -8.14% | 0.40% |
| Materials | XLB | -1.79% | 29.02% | -2.63% | 14.89% |
| Real Estate | XLRE | -2.27% | 26.33% | -18.01% | 5.83% |
| Technology | XLK | 0.49% | 26.33% | -8.77% | 4.56% |
| Utilities | XLU | -1.11% | 29.10% | -13.32% | 5.59% |
| Aerospace & Defense | XAR | -1.17% | 28.72% | -8.92% | 5.06% |
| Biotech | XBI | -4.36% | 23.29% | -8.90% | -7.44% |
| Homebuilder | XHB | -5.17% | 29.98% | -8.93% | -19.34% |
| Retail | XRT | -4.34% | 25.15% | -2.37% | 9.57% |
Does Pharvaris BV outperform its market, is PHVS a Sector Leader?
No, over the last 12 months Pharvaris BV (PHVS) made 36.77%, while its related Sector, the SPDR S&P Biotech (XBI) made 44.21%.
Over the last 3 months PHVS made 34.79%, while XBI made 7.71%.
No, over the last 12 months Pharvaris BV (PHVS) made 36.77%, while its related Sector, the SPDR S&P Biotech (XBI) made 44.21%.
Over the last 3 months PHVS made 34.79%, while XBI made 7.71%.
| Period | PHVS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 27.74% | 4.45% | 1.57% |
| 3 Months | 34.79% | 7.71% | 11.81% |
| 12 Months | 36.77% | 44.21% | 34.15% |